197 related articles for article (PubMed ID: 10956412)
1. Circulating serpin tumor markers SCCA1 and SCCA2 are not actively secreted but reside in the cytosol of squamous carcinoma cells.
Uemura Y; Pak SC; Luke C; Cataltepe S; Tsu C; Schick C; Kamachi Y; Pomeroy SL; Perlmutter DH; Silverman GA
Int J Cancer; 2000 Jul; 89(4):368-77. PubMed ID: 10956412
[TBL] [Abstract][Full Text] [Related]
2. Co-expression of the squamous cell carcinoma antigens 1 and 2 in normal adult human tissues and squamous cell carcinomas.
Cataltepe S; Gornstein ER; Schick C; Kamachi Y; Chatson K; Fries J; Silverman GA; Upton MP
J Histochem Cytochem; 2000 Jan; 48(1):113-22. PubMed ID: 10653592
[TBL] [Abstract][Full Text] [Related]
3. Development of specific monoclonal antibodies and a sensitive discriminatory immunoassay for the circulating tumor markers SCCA1 and SCCA2.
Cataltepe S; Schick C; Luke CJ; Pak SC; Goldfarb D; Chen P; Tanasiyevic MJ; Posner MR; Silverman GA
Clin Chim Acta; 2000 May; 295(1-2):107-27. PubMed ID: 10767398
[TBL] [Abstract][Full Text] [Related]
4. A murine ortholog of the human serpin SCCA2 maps to chromosome 1 and inhibits chymotrypsin-like serine proteinases.
Bartuski AJ; Kamachi Y; Schick C; Massa H; Trask BJ; Silverman GA
Genomics; 1998 Dec; 54(2):297-306. PubMed ID: 9828132
[TBL] [Abstract][Full Text] [Related]
5. SCCA1 and SCCA2 are proteinase inhibitors that map to the serpin cluster at 18q21.3.
Silverman GA; Bartuski AJ; Cataltepe S; Gornstein ER; Kamachi Y; Schick C; Uemura Y
Tumour Biol; 1998; 19(6):480-7. PubMed ID: 9817977
[TBL] [Abstract][Full Text] [Related]
6. Simple modifications of the serpin reactive site loop convert SCCA2 into a cysteine proteinase inhibitor: a critical role for the P3' proline in facilitating RSL cleavage.
Luke C; Schick C; Tsu C; Whisstock JC; Irving JA; Brömme D; Juliano L; Shi GP; Chapman HA; Silverman GA
Biochemistry; 2000 Jun; 39(24):7081-91. PubMed ID: 10852705
[TBL] [Abstract][Full Text] [Related]
7. The squamous cell carcinoma antigen 2 inhibits the cysteine proteinase activity of a major mite allergen, Der p 1.
Sakata Y; Arima K; Takai T; Sakurai W; Masumoto K; Yuyama N; Suminami Y; Kishi F; Yamashita T; Kato T; Ogawa H; Fujimoto K; Matsuo Y; Sugita Y; Izuhara K
J Biol Chem; 2004 Feb; 279(7):5081-7. PubMed ID: 14630915
[TBL] [Abstract][Full Text] [Related]
8. Cross-class inhibition of the cysteine proteinases cathepsins K, L, and S by the serpin squamous cell carcinoma antigen 1: a kinetic analysis.
Schick C; Pemberton PA; Shi GP; Kamachi Y; Cataltepe S; Bartuski AJ; Gornstein ER; Brömme D; Chapman HA; Silverman GA
Biochemistry; 1998 Apr; 37(15):5258-66. PubMed ID: 9548757
[TBL] [Abstract][Full Text] [Related]
9. Squamous cell carcinoma antigen 2 is a novel serpin that inhibits the chymotrypsin-like proteinases cathepsin G and mast cell chymase.
Schick C; Kamachi Y; Bartuski AJ; Cataltepe S; Schechter NM; Pemberton PA; Silverman GA
J Biol Chem; 1997 Jan; 272(3):1849-55. PubMed ID: 8999871
[TBL] [Abstract][Full Text] [Related]
10. The reactive site loop of the serpin SCCA1 is essential for cysteine proteinase inhibition.
Schick C; Brömme D; Bartuski AJ; Uemura Y; Schechter NM; Silverman GA
Proc Natl Acad Sci U S A; 1998 Nov; 95(23):13465-70. PubMed ID: 9811823
[TBL] [Abstract][Full Text] [Related]
11. Molecular cloning of human squamous cell carcinoma antigen 1 gene and characterization of its promoter.
Hamada K; Shinomiya H; Asano Y; Kihana T; Iwamoto M; Hanakawa Y; Hashimoto K; Hirose S; Kyo S; Ito M
Biochim Biophys Acta; 2001 Mar; 1518(1-2):124-31. PubMed ID: 11267667
[TBL] [Abstract][Full Text] [Related]
12. Serum squamous cell carcinoma antigen as an early indicator of response during therapy of cervical cancer.
Markovina S; Wang S; Henke LE; Luke CJ; Pak SC; DeWees T; Pfeifer JD; Schwarz JK; Liu W; Chen S; Mutch D; Wang X; Powell MA; Siegel BA; Dehdashti F; Silverman GA; Grigsby PW
Br J Cancer; 2018 Jan; 118(1):72-78. PubMed ID: 29112685
[TBL] [Abstract][Full Text] [Related]
13. Gene expression of human squamous cell carcinoma antigens 1 and 2 in human cell lines.
Hamada K; Hanakawa Y; Hashimoto K; Iwamoto M; Kihana T; Hirose S; Nakamura M; Ito M
Oncol Rep; 2001; 8(2):347-54. PubMed ID: 11182054
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory mechanism of a cross-class serpin, the squamous cell carcinoma antigen 1.
Masumoto K; Sakata Y; Arima K; Nakao I; Izuhara K
J Biol Chem; 2003 Nov; 278(46):45296-304. PubMed ID: 12949073
[TBL] [Abstract][Full Text] [Related]
15. Aberrant expression of serpin squamous cell carcinoma antigen 2 in human tumor tissues and cell lines: evidence of protection from tumor necrosis factor-mediated apoptosis.
Takeda A; Kajiya A; Iwasawa A; Nakamura Y; Hibino T
Biol Chem; 2002; 383(7-8):1231-6. PubMed ID: 12437110
[TBL] [Abstract][Full Text] [Related]
16. The usefulness of combined measurements of squamous cell carcinoma antigens 1 and 2 in diagnosing atopic dermatitis.
Ohta S; Shibata R; Nakao Y; Azuma Y; Taniguchi K; Arima K; Suzuki S; Shiraishi H; Iwasaka T; Izuhara K
Ann Clin Biochem; 2012 May; 49(Pt 3):277-84. PubMed ID: 22402915
[TBL] [Abstract][Full Text] [Related]
17. Relative levels of SCCA2 and SCCA1 mRNA in primary tumors predicts recurrent disease in squamous cell cancer of the head and neck.
Stenman J; Hedström J; Grénman R; Leivo I; Finne P; Palotie A; Orpana A
Int J Cancer; 2001 Jan; 95(1):39-43. PubMed ID: 11241309
[TBL] [Abstract][Full Text] [Related]
18. Tumor-associated serpin, squamous cell carcinoma antigen stimulates matrix metalloproteinase-9 production in cervical squamous cell carcinoma cell lines.
Sueoka K; Nawata S; Nakagawa T; Murakami A; Takeda O; Suminami Y; Kato H; Sugino N
Int J Oncol; 2005 Nov; 27(5):1345-53. PubMed ID: 16211231
[TBL] [Abstract][Full Text] [Related]
19. Role of squamous cell carcinoma antigen 1 expression in the invasive potential of head and neck squamous cell carcinoma.
Nakashima T; Yasumatsu R; Kuratomi Y; Masuda M; Kuwano T; Toh S; Umezaki T; Cataltepe S; Silverman GA; Komune S
Head Neck; 2006 Jan; 28(1):24-30. PubMed ID: 16155915
[TBL] [Abstract][Full Text] [Related]
20. Squamous cell carcinoma antigen isoforms in serum from cervical cancer patients.
Roijer E; de Bruijn HW; Dahlén U; ten Hoor K; Lundin M; Nilsson K; Soderstrom K; Nilsson O
Tumour Biol; 2006; 27(3):142-52. PubMed ID: 16641548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
